Loading clinical trials...
Loading clinical trials...
KaSP is a multimodal observational study with the goal of clarifying underlying mechanisms that cause psychotic disorders, such as schizophrenia. Participants with psychotic symptoms are recruited ear...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Karolinska Institutet
Collaborators
NCT06939088 · Alcohol Use Disorder, Alcohol Abuse/Dependence, and more
NCT02928965 · Schizophrenia and Disorders With Psychotic Features
NCT02307396 · Schizophrenia, Schizophrenia and Disorders With Psychotic Features, and more
NCT00137189 · Mental Disorders, Mood Disorders, and more
NCT02240173 · Schizophrenia and Disorders With Psychotic Features
SLSO Psykiatri Stockholm in collaboration w Karolinska Institutet
Stockholm
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions